Results 181 to 187 of about 1,935,200 (187)

EXAMINATION of New Drug-Eluting Stents—Top of the Class!

Lancet, The, 2012

exaly  

A Randomized Comparison of Drug-Eluting Balloon Versus Everolimus-Eluting Stent in Patients With Bare-Metal Stent-in-Stent Restenosis: The RIBS V Clinical Trial (Restenosis Intra-Stent of Bare Metal Stents: Paclitaxel-Eluting Balloon vs. Everolimus-Eluting Stent).

Journal of the American College of Cardiology, 2014
Pilar Jiménez-Quevedo, Ángel Cequier
exaly  

Mechanisms of Controlled Drug Release From Drug-Eluting Stents

Advanced Drug Delivery Reviews, 2006
Kinam Park, Ghanashyam Acharya
exaly  

Late Thrombosis in Drug-Eluting Coronary Stents After Discontinuation of Antiplatelet Therapy

Lancet, The, 2004

exaly  

Unrestricted Randomised Use of Two New Generation Drug-Eluting Coronary Stents: 2-Year Patient-Related Versus Stent-Related Outcomes From the RESOLUTE All Comers Trial

Lancet, The, 2011
Pascal Vranckx, Stephan Windecker, Sigmund Silber   +2 more
exaly  

Hypersensitivity Cases Associated With Drug-Eluting Coronary Stents: A Review of Available Cases From the Research on Adverse Drug Events and Reports (RADAR) Project.

Journal of the American College of Cardiology, 2006
Jonathan Nebeker, Paul Yarnold, Brian K Whisenant   +2 more
exaly  

The Taxus™ Drug-Eluting Stent: A New Paradigm in Controlled Drug Delivery

Advanced Drug Delivery Reviews, 2006
exaly